"Liver Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pathological processes of the LIVER.
| Descriptor ID |
D008107
|
| MeSH Number(s) |
C06.552
|
| Concept/Terms |
Liver Diseases- Liver Diseases
- Disease, Liver
- Diseases, Liver
- Liver Disease
Liver Dysfunction- Liver Dysfunction
- Dysfunction, Liver
- Dysfunctions, Liver
- Liver Dysfunctions
|
Below are MeSH descriptors whose meaning is more general than "Liver Diseases".
Below are MeSH descriptors whose meaning is more specific than "Liver Diseases".
This graph shows the total number of publications written about "Liver Diseases" by people in this website by year, and whether "Liver Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 2 | 2 | 4 |
| 1995 | 1 | 0 | 1 |
| 1996 | 0 | 2 | 2 |
| 1998 | 2 | 0 | 2 |
| 1999 | 0 | 1 | 1 |
| 2000 | 2 | 0 | 2 |
| 2001 | 0 | 2 | 2 |
| 2002 | 4 | 3 | 7 |
| 2003 | 4 | 3 | 7 |
| 2004 | 4 | 0 | 4 |
| 2005 | 4 | 1 | 5 |
| 2006 | 0 | 2 | 2 |
| 2007 | 4 | 3 | 7 |
| 2008 | 2 | 2 | 4 |
| 2009 | 4 | 1 | 5 |
| 2010 | 3 | 1 | 4 |
| 2011 | 6 | 0 | 6 |
| 2012 | 2 | 1 | 3 |
| 2013 | 5 | 0 | 5 |
| 2014 | 2 | 1 | 3 |
| 2015 | 4 | 0 | 4 |
| 2016 | 3 | 2 | 5 |
| 2017 | 2 | 1 | 3 |
| 2018 | 3 | 1 | 4 |
| 2019 | 6 | 0 | 6 |
| 2020 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Liver Diseases" by people in Profiles.
-
Liu S, Luttrell LM, Premont RT, Rockey DC. Reply to Schierwagen et al.: ß-Arrestins in liver disease. Proc Natl Acad Sci U S A. 2020 11 03; 117(44):27085-27086.
-
Liu S, Luttrell LM, Premont RT, Rockey DC. ß-Arrestin2 is a critical component of the GPCR-eNOS signalosome. Proc Natl Acad Sci U S A. 2020 05 26; 117(21):11483-11492.
-
Bian J, Schreiner AD, Rockey DC. Abnormal Liver Enzymes. J Gen Intern Med. 2019 09; 34(9):1676.
-
Rockey DC. Editorial: Advances in Hepatology: 2019. Curr Opin Gastroenterol. 2019 05; 35(3):135-136.
-
Schreiner AD, Bian J, Zhang J, Kirkland EB, Heincelman ME, Schumann SO, Mauldin PD, Moran WP, Rockey DC. When Do Clinicians Follow-up Abnormal Liver Tests in Primary Care? Am J Med Sci. 2019 08; 358(2):127-133.
-
Heslop JA, Duncan SA. The Use of Human Pluripotent Stem Cells for Modeling Liver Development and Disease. Hepatology. 2019 03; 69(3):1306-1316.
-
Nian M, Li QQ, Bloom M, Qian ZM, Syberg KM, Vaughn MG, Wang SQ, Wei Q, Zeeshan M, Gurram N, Chu C, Wang J, Tian YP, Hu LW, Liu KK, Yang BY, Liu RQ, Feng D, Zeng XW, Dong GH. Liver function biomarkers disorder is associated with exposure to perfluoroalkyl acids in adults: Isomers of C8 Health Project in China. Environ Res. 2019 05; 172:81-88.
-
Lin HC, Kasi N, Quiros JA. Alpha1-Antitrypsin Deficiency: Transition of Care for the Child With AAT Deficiency into Adulthood. Curr Pediatr Rev. 2019; 15(1):53-61.
-
Bian J, Schreiner AD, Zhang J, Schumann SO, Rockey DC, Mauldin PD, Moran WP. Associations of Race with Follow-up Patterns After Initial Abnormal Liver Tests in Primary Care. J Gen Intern Med. 2018 10; 33(10):1618-1620.
-
Rockey DC. Advances in Hepatology: 2018. Curr Opin Gastroenterol. 2018 05; 34(3):121-122.